S1
Silica microsphere-resorcinol composite embedded collagen
scaffolds impart scar-less healing of chronic infected burns in type-I
diabetic and non-diabetic rats
Kalirajan Cheirmadurai,a,b Palanisamy Thanikaivelan* a,b
aAdvanced Materials Laboratory, Central Leather Research Institute (Council of Scientific and
Industrial Research), Adyar, Chennai 600020, India.
bUniversity of Madras, Chepauk, Chennai 600005, India.
E-mail: [email protected]; [email protected]
Electronic Supplementary Material (ESI) for Biomaterials Science.This journal is © The Royal Society of Chemistry 2020
S2
Fig. S1. 13C solid state NMR spectra of FSP and OFSP
S3
Fig. S2. (a) FT-IR spectra of the FSP and OFSP. (b) Magnified FT-IR spectra in the range 2000
to 600 cm-1 showing the aldehyde peak clearly.
S4
Fig. S3. TEM image of the pristine silica microspheres.
S5
Fig. S4. FT-IR spectra of the silica microsphere, resorcinol and Si@Res composite.
S6
Fig. S5. (a) FT-IR and (b) CD spectra of the native collagen, Coll/OFSP/Si@Res 2% and
Coll/OFSP/Si@Res 5% scaffolds.
S7
Fig. S6. DSC thermogram of the Coll/OFSP alone.
S8
Fig. S7. (a) Antioxidant activity and (b) hemolytic activity of the collagen (1),
Coll/OFSP/Si@Res 2% (2) and Coll/OFSP/Si@Res 5% (3) scaffolds.
S9
Fig. S8. Digital images of the rats (a) before and (b) after burn wound creation.
Fig. S9. H&E staining image of the eschar tissue collected after burn wound creation (0th day)
S10
Fig. S10. (a) H&E and (b) Masson’s trichrome staining of the granulation tissue collected on 8th
and 16th day of healing from the non-diabetic open wound (Non.dia.OW), native collagen
(Non.dia.Coll) and hybrid scaffold (Non.dia.Coll/OFSP/Si@Res 5%) treated animal groups. (BV
represents blood vessels, FB represents fibroblasts and ED represents epidermal layer in the
image.)
S11
Fig. S11. H&E images of the newly regenerated skin collected after 24 days of healing followed
by 30 days of maturation from the non-diabetic open wound (Non.dia.OW), native collagen
(Non.dia.Coll) and hybrid scaffold (Non.dia.Coll/OFSP/Si@Res 5%) treated animal groups at (a,
d and g) lower magnification to show the full skin structure and (b, e and h) higher magnification
to show the thick epidermis, respectively. In the image, BV represents blood vessels, ED
represents epidermal layer, SG represents sebaceous gland, KL represents keratinized layer and
HF represents hair follicle. (c, f and i) Masson’s trichrome staining of the regenerated skin
collected from the non-diabetic open wound (Non.dia.OW), native collagen (Non.dia.Coll) and
hybrid scaffold (Non.dia.Coll/OFSP/Si@Res 5%) treated animal groups. (j) Thickness of the
epidermis in non-diabetic unwounded skin and experimental groups. *Statistically significant, p
< 0.05 vs. non-diabetic open wound group (Non.dia.OW), #statistically significant, p < 0.05 vs.
non-diabetic collagen scaffolds treated group (Non.dia.Coll), ♦statistically significant, p < 0.05
vs. Exp. (k) Scar elevation index for all the non-diabetic experimental groups. †Statistically
S12
significant, p < 0.05 vs. non-diabetic open wound group (Non.dia.OW), ҂statistically significant,
p < 0.05 vs. non-diabetic collagen scaffolds treated group (Non.dia.Coll).
Fig. S12. H&E staining of the unwounded skin at (a) lower and (b) higher magnification,
respectively. (c) Masson’s trichrome staining of the unwounded skin.
S13
Fig. S13. CD31 immunohistochemistry staining of the newly regenerated skin collected from the
non-diabetic (a) open wound (Non.dia.OW), (b) native collagen (Non.dia.Coll) and (c) hybrid
scaffold (Non.dia.Coll/OFSP/Si@Res 5%) treated animal groups. Arrows in the images show the
blood vessels. (d) Number of blood vessels calculated from the CD31 images of the different
non-diabetic animal groups. *Statistically significant, p < 0.05 vs. non-diabetic open wound
group (Non.dia.OW), #statistically significant, p < 0.05 vs. non-diabetic collagen scaffolds
treated group (Non.dia.Coll). TGF-β3 immunohistochemistry staining of the regenerated skin
collected from the non-diabetic (e) open wound (Non.dia.OW), (f) native collagen (Non.dia.Coll)
and (g) hybrid scaffold (Non.dia.Coll/OFSP/Si@Res 5%) treated animal groups.
S14
Fig. S14. Enlarged TGF-β3 immunohistochemistry staining of the regenerated skin collected
from the hybrid scaffold treated (a) diabetic and (b) non-diabetic animals to show the expression
of TGF-β3 clearly.